Etidronate disodium is used as a bisphosphonate bone resorption inhibitor. Etidronic acid is used as a calcium regulator. Etidronic acid is a bisphosphonate antiresorptive agent.
RP Heaney.; PD Saville. Etidronate disodium in postmenopausal osteoporosis. Clinical pharmacology and therapeutics. 1976, 20(5), 593-604.
N Shiraishi.; K Kitamura.;T Miyoshi.; M Adachi. Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) byetidronate disodium. American Journal of Kidney Diseases. 2006, 48(1), 151-154.
Hazard Statements: H302
Harmful if swallowed.
Precautionary Statements: P264-P270-P301+P312a-P330-P501a
Wash thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. Dispose of contents/container in accordance with local/regional/national/international regulations.